Therapeutic effects of liposome-enveloped Ligusticum chuanxiong essential oil on hypertrophic scars in the rabbit ear model

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Zhang, Hong ^a,b   Ran, Xia ^a,c   Hu, Chang Ling ^a   Qin, Lu Ping ^a   Lu, Ying ^a   Peng, Cheng ^b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c EAST CHINA NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; COLLAGEN TYPE 1; COLLAGEN TYPE 3; CONTRACTUBEX; ESSENTIAL OIL; INTERSTITIAL COLLAGENASE; LIGUSTICUM CHUANXIONG ESSENTIAL OIL; LIPOSOME; MESSENGER RNA; PLACEBO; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; EAR; EXCISION; FEMALE; FIBROBLAST; GENE EXPRESSION; HISTOPATHOLOGY; HYPERTROPHIC SCAR; LIGUSTICUM CHUANXIONG; NONHUMAN; PROTEIN EXPRESSION; RABBIT; RHIZOME; SCAR; STAINING; TREATMENT DURATION; ANIMAL; CHEMISTRY; DISEASE MODEL; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIGUSTICUM; METABOLISM; NICK END LABELING; PATHOLOGY;

ANIMALS; CASPASE 3; CASPASE 9; CHEMISTRY, PHARMACEUTICAL; CICATRIX, HYPERTROPHIC; COLLAGEN TYPE I; COLLAGEN TYPE III; DISEASE MODELS, ANIMAL; EAR; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IN SITU NICK-END LABELING; LIGUSTICUM; LIPOSOMES; MATRIX METALLOPROTEINASE 1; OILS, VOLATILE; RABBITS; RNA, MESSENGER; STAINING AND LABELING; TRANSFORMING GROWTH FACTOR BETA;

EID: 84857408168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031157     Document Type: Article

References (41)

1. O'Leary R, Wood EJ, Guillou PJ, (2002) Pathological scarring: strategic interventions. Eur J Surg 168: 523-534.
2. Bock O, Schmid-Ott G, Malewski P, Mrowietz U, (2006) Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 297: 433-438.
3. Mazharinia N, Aghaei S, Shayan Z, (2007) Dermatology Life Quality Index (DLQI) scores in burn victims after revival. J Burn Care Res 28: 312-317.
4. Reish RG, Eriksson E, (2008) Scar treatments: preclinical and clinical studies. J Am Coll Surg 206: 719-730.
5. Bloemen MCT, van der Veer WM, Ulrich MMW, van Zuijlen PPM, Niessen FB, et al. (2009) Prevention and curative management of hypertrophic scar formation. Burns 35: 463-475.
6. Zhang H, Xing WW, Li YS, Zhu Z, Wu JZ, et al. (2008) Effects of a traditional Chinese herbal preparation on osteoblasts and osteoclasts. Maturitas 61: 334-339.
7. Du J, Sun LN, Xing WW, Huang BK, Jia M, et al. (2009) Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters. Phytomedicine 16: 652-658.
8. Wu JG, Wu JZ, Sun LN, Han T, Du J, et al. (2009) Ameliorative effects of arctiin from Arctium lappa on experimental glomerulonephritis in rats. Phytomedicine 16: 1033-1041.
9. Xing WW, Wu JZ, Jia M, Du J, Zhang H, et al. (2009) Effects of polydatin from Polygonum cuspidatum on lipid profile in hyperlipidemic rabbits. Biomed Pharmacother 63: 457-462.
10. Zhang H, Han T, Yu CH, Rahman K, Qin LP, et al. (2007) Ameliorating effects of essential oil from Acori graminei rhizoma on learning and memory in aged rats and mice. J pharm pharmacol 59: 301-309.
11. Zhang H, Han T, Zhang L, Yu CH, Wan DG, et al. (2008) Effects of tenuifolin extracted from radix polygalae on learning and memory: A behavioral and biochemical study on aged and amnesic mice. Phytomedicine 15: 587-594.
12. China Pharmacopoeia Committee (2005) Chinese Pharmacopoeia, Vol. 1 Beijing Chemical Industry Press 2005.
13. Chan SSK, Choi AOK, Jones RL, Lin G, (2006) Mechanisms underlying the vasorelaxing effects of butylidenephthalide, an active constituent of Ligusticum chuanxiong, in rat isolated aorta. Euro J Pharmacol 537: 111-117.
14. Peng C, Xie XF, Wang L, Guo L, Hu TL, (2009) Pharmacodynamic action and mechanism of volatile oil from rhizoma Ligustici Chuanxiong Hort. on treating headache. Phytomedicine 16: 25-34.
15. Jeong JB, Ju SY, Park JH, Lee JR, Yun KW, et al. (2009) Antioxidant activity in essential oils of Cnidium officinale Makino and Ligusticum chuanxiong Hort. and their inhibitory effects on DNA damage and apoptosis induced by ultraviolet B in mammalian cell. Cancer Epidemiol 33: 41-46.
16. Hou YZ, Zhao GR, Yang J, Yuan JY, Zhu GG, et al. (2004) Protective effect of Ligusticum chuanxiong and Angelica sinensis on endothelial cell damage induced by hydrogen peroxide. Life Sci 75: 1775-1786.
17. Sim Y, Shin S, (2008) Combinatorial anti-Trichophyton effects of Ligusticum chuanxiong essential oil components with antibiotics. Arch Pharm Res 31: 497-502.
18. Wu JG, Ma L, Zhang SY, Zhu ZZ, Zhang H, et al. (2011) Essential oil from rhizomes of Ligusticum chuanxiong induces apoptosis in hypertrophic scar fibroblasts. Pharm Biol 49: 86-93.
19. Wu JG, Wei YJ, Ran X, Zhang H, Nian H, et al. (2011) Inhibitory effects of essential oil from rhizomes of Ligusticum chuanxiong on hypertrophic scarring in the rabbit ear model. Pharm Biol 49: 764-769.
20. Egbaria K, Weiner N, (1990) Liposomes as a topical drug delivery system. Adv Drug Deliver Rev 5: 287-300.
21. Morris DE, Wu L, Zhao LL, Bolton L, Roth SI, et al. (1997) Acute and chronic animal models for excessive dermal scarring: quantitative studies. Plast Reconstr Surg 100: 674-681.
22. Niu F, Niu Y, Chen Y, (2004) Establishment of rabbits hypertrophic scars model. China Medical Engineering 12: 12-15.
23. Song B, ZhangW, Guo S, Han Y, Zhang Y, et al. (2009) Adenovirus-mediated METH1 gene expression inhibits hypertrophic scarring in a rabbit ear model. Wound Rep Reg 17: 559-568.
24. Yu R, Song Y, Chen JJ, Liu XX, Cen Y, (2010) Establishment of an animal model of rabbit's ear with intermediate stage hypertrophic scar. West China Medical Journal 25: 1209-1212.
25. Niessen FB, Spauwen PH, Schalkwijk J, Kon M, (1999) On the nature of hypertrophic scars and keloids: A review. Plast Reconstr Surg 104: 1435-1458.
26. Clark J, Cheng J, Leung K, (1996) Mechanical properties of normal skin and hypertrophic scars. Burns 22: 443-446.
27. Beldon P, (2000) Abnormal scar formation in wound healing. Nursing times 96: 44.
28. Schaffer M, Becker HD, (1999) Immune regulation of wound healing. Der Chirurg 70: 897-908.
29. Hayakawa T, Hashimoto Y, Myokei Y, Aoyama H, Izawa Y, (1979) Changes in type of collagen during the development of human post-burn hypertrophic scars. Clin Chim Acta 93: 119-125.
30. Dasu MR, Hawkins HK, Barrow RE, Xue H, Herndon DN, (2004) Gene expression profiles from hypertrophic scar fibroblasts before and after IL-6 stimulation. J Pathol 202: 476-485.
31. Schmid P, Itin P, Cherry G, Bi C, Cox DA, (1998) Enhanced expression of transforming growth factor-beta type I and type II receptors in wound granulation tissue and hypertrophic scar. Am J Pathol 152: 485-93.
32. Cande C, Vahsen N, Garrido C, Kroemer G, (2004) Apoptosis-inducing factor (AIF): caspase-independent after all. Cell Death Differ 11: 591-595.
33. Chipuk JE, Green DR, (2005) Do inducers of apoptosis trigger caspase-independent cell death? Nat Rev Mol Cell Biol 6: 268-275.
34. Pirnia F, Schneider E, Betticher D, Borner M, (2002) Mitomycin C induces apoptosis and caspase-8 and-9 processing through a caspase-3 and Fas-independent pathway. Cell Death Differ 9: 905.
35. Akasaka Y, Ito K, Fujita K, Komiyama K, Ono I, et al. (2005) Activated caspase expression and apoptosis increase in keloids: cytochrome c release and caspase-9 activation during the apoptosis of keloid fibroblast lines. Wound Repair Regen 13: 373-382.
36. Rodriguez J, Lazebnik Y, (1999) Caspase-9 and APAF-1 form an active holoenzyme. Gene Dev 13: 3179-3184.
37. Wang XD, (2001) The expanding role of mitochondria in apoptosis. Gene Dev 15: 2922-2933.
38. Hengartner MO, (2000) The biochemistry of apoptosis. Nature 407: 770-776.
39. Wu M, Xu LG, Li X, Zhai Z, Shu HB, (2002) AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis. J Biol Chem 277: 25617.
40. Tuan TL, Nichter LS, (1998) The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4: 19-24.
41. Kryger ZB, Sisco M, Roy NK, Lu L, Rosenberg D, et al. (2007) Temporal expression of the transforming growth factor-beta pathway in the rabbit ear model of wound healing and scarring. J Am Coll Surgeons 205: 78-88.